OBJECTIVE: To describe a mixed-methods approach to develop and test a basic behavioral science-informed intervention to motivate behavior change in 3 high-risk clinical populations. Our theoretically derived intervention comprised a combination of positive affect and self-affirmation (PA/SA), which we applied to 3 clinical chronic disease populations. METHOD: We employed a sequential mixed methods model (EVOLVE) to design and test the PA/SA intervention in order to increase physical activity in people with coronary artery disease (post-percutaneous coronary intervention [PCI]) or asthma (ASM) and to improve medication adherence in African Americans with hypertension (HTN). In an initial qualitative phase, we explored participant values and beliefs. We next pilot tested and refined the intervention and then conducted 3 randomized controlled trials with parallel study design. Participants were randomized to combined PA/SA versus an informational control and were followed bimonthly for 12 months, assessing for health behaviors and interval medical events. RESULTS: Over 4.5 years, we enrolled 1,056 participants. Changes were sequentially made to the intervention during the qualitative and pilot phases. The 3 randomized controlled trials enrolled 242 participants who had undergone PCI, 258 with ASM, and 256 with HTN (n = 756). Overall, 45.1% of PA/SA participants versus 33.6% of informational control participants achieved successful behavior change (p = .001). In multivariate analysis, PA/SA intervention remained a significant predictor of achieving behavior change (p < .002, odds ratio = 1.66), 95% CI [1.22, 2.27], controlling for baseline negative affect, comorbidity, gender, race/ethnicity, medical events, smoking, and age. CONCLUSIONS: The EVOLVE method is a means by which basic behavioral science research can be translated into efficacious interventions for chronic disease populations.
RCT Entities:
OBJECTIVE: To describe a mixed-methods approach to develop and test a basic behavioral science-informed intervention to motivate behavior change in 3 high-risk clinical populations. Our theoretically derived intervention comprised a combination of positive affect and self-affirmation (PA/SA), which we applied to 3 clinical chronic disease populations. METHOD: We employed a sequential mixed methods model (EVOLVE) to design and test the PA/SA intervention in order to increase physical activity in people with coronary artery disease (post-percutaneous coronary intervention [PCI]) or asthma (ASM) and to improve medication adherence in African Americans with hypertension (HTN). In an initial qualitative phase, we explored participant values and beliefs. We next pilot tested and refined the intervention and then conducted 3 randomized controlled trials with parallel study design. Participants were randomized to combined PA/SA versus an informational control and were followed bimonthly for 12 months, assessing for health behaviors and interval medical events. RESULTS: Over 4.5 years, we enrolled 1,056 participants. Changes were sequentially made to the intervention during the qualitative and pilot phases. The 3 randomized controlled trials enrolled 242 participants who had undergone PCI, 258 with ASM, and 256 with HTN (n = 756). Overall, 45.1% of PA/SA participants versus 33.6% of informational control participants achieved successful behavior change (p = .001). In multivariate analysis, PA/SA intervention remained a significant predictor of achieving behavior change (p < .002, odds ratio = 1.66), 95% CI [1.22, 2.27], controlling for baseline negative affect, comorbidity, gender, race/ethnicity, medical events, smoking, and age. CONCLUSIONS: The EVOLVE method is a means by which basic behavioral science research can be translated into efficacious interventions for chronic disease populations.
Authors: Gbenga O Ogedegbe; Carla Boutin-Foster; Martin T Wells; John P Allegrante; Alice M Isen; Jared B Jobe; Mary E Charlson Journal: Arch Intern Med Date: 2012-01-23
Authors: Carol A Mancuso; Tiffany N Choi; Heidi Westermann; Suzanne Wenderoth; James P Hollenberg; Martin T Wells; Alice M Isen; Jared B Jobe; John P Allegrante; Mary E Charlson Journal: Arch Intern Med Date: 2012-01-23
Authors: J Y Lee; J W Kusek; P G Greene; S Bernhard; K Norris; D Smith; B Wilkening; J T Wright Journal: Am J Hypertens Date: 1996-08 Impact factor: 2.689
Authors: Aamir Javaid; Daniel H Steinberg; Ashesh N Buch; Paul J Corso; Steven W Boyce; Tina L Pinto Slottow; Probal K Roy; Peter Hill; Teruo Okabe; Rebecca Torguson; Kimberly A Smith; Zhenyi Xue; Natalie Gevorkian; William O Suddath; Kenneth M Kent; Lowell F Satler; Augusto D Pichard; Ron Waksman Journal: Circulation Date: 2007-09-11 Impact factor: 29.690
Authors: Carla Boutin-Foster; Ebony Scott; Jennifer Melendez; Anna Rodriguez; Rosio Ramos; Balavenkatesh Kanna; Walid Michelen Journal: Am J Public Health Date: 2013-10-17 Impact factor: 9.308
Authors: Susan M Czajkowski; Lynda H Powell; Nancy Adler; Sylvie Naar-King; Kim D Reynolds; Christine M Hunter; Barbara Laraia; Deborah H Olster; Frank M Perna; Janey C Peterson; Elissa Epel; Josephine E Boyington; Mary E Charlson Journal: Health Psychol Date: 2015-02-02 Impact factor: 4.267
Authors: Judith T Moskowitz; Elaine O Cheung; Karin E Snowberg; Alice Verstaen; Jennifer Merrilees; John M Salsman; Glenna A Dowling Journal: Health Psychol Date: 2019-05 Impact factor: 4.267
Authors: John M Salsman; James E Pustejovsky; Stephen M Schueller; Rosalba Hernandez; Mark Berendsen; Laurie E Steffen McLouth; Judith T Moskowitz Journal: J Cancer Surviv Date: 2019-11-19 Impact factor: 4.442
Authors: Judith T Moskowitz; Adam W Carrico; Larissa G Duncan; Michael A Cohn; Elaine O Cheung; Abigail Batchelder; Lizet Martinez; Eisuke Segawa; Michael Acree; Susan Folkman Journal: J Consult Clin Psychol Date: 2017-03-23